STOCK TITAN

[144] Nutanix, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Nutanix, Inc. (NTNX) filed a Form 144 reporting a proposed sale of 11,391 common shares valued at $892,413.09 to be sold through Morgan Stanley Smith Barney on NASDAQ on 09/16/2025. The filing notes total shares outstanding of 268,077,453, showing the proposed sale is a small fraction of the company’s outstanding common stock. The shares were acquired on 09/15/2025 as 2,100 restricted stock and 9,291 performance shares, with payment not applicable. The filer affirms they have no undisclosed material adverse information and no other securities were sold in the past three months.

Nutanix, Inc. (NTNX) ha presentato un Modulo 144 segnalando una vendita proposta di 11.391 azioni ordinarie, valutate 892.413,09 dollari, da vendere tramite Morgan Stanley Smith Barney su NASDAQ il 16/09/2025. L'invio indica un totale di azioni ordinarie in circolazione di 268.077.453, mostrando che la vendita proposta è una piccola frazione del capitale azionario ordinario dell'azienda. Le azioni sono state acquisite il 15/09/2025 come 2.100 azioni soggette a vincolo e 9.291 azioni legate alle prestazioni, con pagamento non applicabile. Il dichiarante afferma di non possedere informazioni materiali avverse non divulgate e che non sono stati venduti altri strumenti in titoli nelle tre mesi precedenti.

Nutanix, Inc. (NTNX) presentó un Formulario 144 informando la venta propuesta de 11.391 acciones comunes con un valor de 892,413.09 dólares que se venderán a través de Morgan Stanley Smith Barney en NASDAQ el 16/09/2025. El escrito señala un total de 268,077,453 acciones en circulación, mostrando que la venta propuesta es una pequeña fracción del capital social ordinario de la empresa. Las acciones se adquirieron el 15/09/2025 como 2.100 acciones restringidas y 9.291 acciones de rendimiento, sin pago aplicable. El presentante afirma no poseer información material adversa no divulgada y que no se vendieron otros valores en los últimos tres meses.

Nutanix, Inc. (NTNX) 회사가 NASDAQ에서 2025년 9월 16일 Morgan Stanley Smith Barney를 통해 매도될 예정인 11,391주(주당 가치 892,413.09달러) 보통주 매도를 보고하는 Form 144를 제출했습니다. 이 서류에 따르면 총 발행 주식은 268,077,453주로 이 매도 예정 주식은 기업의 발행 보통주 중 아주 작은 비율에 불과합니다. 해당 주식은 2025년 9월 15일에 2,100주 제한주9,291주 성과주로 취득되었으며, 지급은 해당되지 않습니다. 제출자는 미공개 중요 악재 정보가 없고 지난 3개월 동안 다른 증권이 매도되지 않았다고 확인합니다.

Nutanix, Inc. (NTNX) a déposé un formulaire 144 signalant la vente proposée de 11 391 actions ordinaires évaluées à 892 413,09 dollars à vendre par l'intermédiaire de Morgan Stanley Smith Barney sur le NASDAQ le 16/09/2025. L'enregistrement indique un total d'actions en circulation de 268 077 453, montrant que la vente proposée représente une petite fraction des actions ordinaires de la société. Les actions ont été acquises le 15/09/2025 en tant que 2 100 actions restreintes et 9 291 actions liées à la performance, sans paiement applicable. Le signataire affirme qu'il n'a pas d'informations material adverse non divulguées et qu'aucun autre titre n'a été vendu au cours des trois derniers mois.

Nutanix, Inc. (NTNX) hat ein Formular 144 eingereicht und eine geplante Veräußerung von 11.391 Stammaktien im Wert von 892.413,09 USD angekündigt, die über Morgan Stanley Smith Barney an der NASDAQ am 16.09.2025 verkauft werden sollen. Die Einreichung weist insgesamt 268.077.453 ausstehende Aktien aus und zeigt, dass der geplante Verkauf nur einen kleinen Bruchteil des ausstehenden Stammkapitals des Unternehmens darstellt. Die Aktien wurden am 15.09.2025 als 2.100 eingeschränkte Aktien und 9.291 Performance-Aktien erworben, eine Zahlung ist nicht zutreffend. Der Einreicher versichert, dass er über keine unangekündigten wesentlichen negativen Informationen verfügt und in den letzten drei Monaten keine weiteren Wertpapiere verkauft wurden.

قدمت شركة Nutanix, Inc. (NTNX) نموذج 144 للإبلاغ عن بيع مقترح لـ 11,391 سهماً عادياً قيمتها 892,413.09 دولاراً ليتم بيعها من خلال Morgan Stanley Smith Barney في NASDAQ في 16/09/2025. تشير التسجيل إلى إجمالي الأسهم القائمة البالغ 268,077,453 سهم، مما يُظهر أن البيع المقترح يمثل جزءاً صغيراً من رأس المال العادي للشركة. تم اكتساب الأسهم في 15/09/2025 كـ 2,100 أسهم مقيدة و 9,291 أسهم أداء، مع عدم اعتبار الدفع قابلاً للتطبيق. يؤكد المصرّف أنه لا توجد معلومات سلبية مادية غير معلنة ولا تم بيع أوراق مالية أخرى في الـ3 أشهر الماضية.

Nutanix, Inc. (NTNX) 提交了 Form 144,报告拟议出售 11,391 股普通股,估值 892,413.09 美元,将通过 Morgan Stanley Smith Barney 于 2025/09/16 在 NASDAQ 出售。 该备案显示流通在外股数为 268,077,453 股,表明拟议的出售仅占公司流通普通股的一小部分。 这些股票在 2025/09/15 获得,为 2,100 股限售股9,291 股绩效股,无适用的付款。 申报人声明他们没有未披露的重大不利信息,且在过去三个月内没有出售其他证券。

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Insider plans to sell 11,391 shares (~$0.89M) — de minimis relative to total float; likely not material to valuation.

The Form 144 documents an imminent sale executed via Morgan Stanley Smith Barney for 11,391 common shares with an aggregate market value of $892,413.09 against 268,077,453 shares outstanding. The holdings were acquired one day prior as restricted and performance awards. From a market-impact perspective, the sale represents roughly 0.0042% of outstanding shares, indicating negligible dilution or immediate liquidity pressure on the stock. Disclosure appears routine and compliant with Rule 144 reporting requirements.

TL;DR: Filing is a standard insider disclosure with required attestation; timing and source of shares are clearly stated.

The notice specifies the nature of acquisition (restricted stock and performance shares) and includes the filer’s attestation regarding undisclosed material information, which satisfies the procedural elements of Rule 144 filings. No prior sales in the past three months are reported. Governance implications are limited given the small size of the proposed sale relative to total shares outstanding; the filing enhances transparency about executive compensation-related sales.

Nutanix, Inc. (NTNX) ha presentato un Modulo 144 segnalando una vendita proposta di 11.391 azioni ordinarie, valutate 892.413,09 dollari, da vendere tramite Morgan Stanley Smith Barney su NASDAQ il 16/09/2025. L'invio indica un totale di azioni ordinarie in circolazione di 268.077.453, mostrando che la vendita proposta è una piccola frazione del capitale azionario ordinario dell'azienda. Le azioni sono state acquisite il 15/09/2025 come 2.100 azioni soggette a vincolo e 9.291 azioni legate alle prestazioni, con pagamento non applicabile. Il dichiarante afferma di non possedere informazioni materiali avverse non divulgate e che non sono stati venduti altri strumenti in titoli nelle tre mesi precedenti.

Nutanix, Inc. (NTNX) presentó un Formulario 144 informando la venta propuesta de 11.391 acciones comunes con un valor de 892,413.09 dólares que se venderán a través de Morgan Stanley Smith Barney en NASDAQ el 16/09/2025. El escrito señala un total de 268,077,453 acciones en circulación, mostrando que la venta propuesta es una pequeña fracción del capital social ordinario de la empresa. Las acciones se adquirieron el 15/09/2025 como 2.100 acciones restringidas y 9.291 acciones de rendimiento, sin pago aplicable. El presentante afirma no poseer información material adversa no divulgada y que no se vendieron otros valores en los últimos tres meses.

Nutanix, Inc. (NTNX) 회사가 NASDAQ에서 2025년 9월 16일 Morgan Stanley Smith Barney를 통해 매도될 예정인 11,391주(주당 가치 892,413.09달러) 보통주 매도를 보고하는 Form 144를 제출했습니다. 이 서류에 따르면 총 발행 주식은 268,077,453주로 이 매도 예정 주식은 기업의 발행 보통주 중 아주 작은 비율에 불과합니다. 해당 주식은 2025년 9월 15일에 2,100주 제한주9,291주 성과주로 취득되었으며, 지급은 해당되지 않습니다. 제출자는 미공개 중요 악재 정보가 없고 지난 3개월 동안 다른 증권이 매도되지 않았다고 확인합니다.

Nutanix, Inc. (NTNX) a déposé un formulaire 144 signalant la vente proposée de 11 391 actions ordinaires évaluées à 892 413,09 dollars à vendre par l'intermédiaire de Morgan Stanley Smith Barney sur le NASDAQ le 16/09/2025. L'enregistrement indique un total d'actions en circulation de 268 077 453, montrant que la vente proposée représente une petite fraction des actions ordinaires de la société. Les actions ont été acquises le 15/09/2025 en tant que 2 100 actions restreintes et 9 291 actions liées à la performance, sans paiement applicable. Le signataire affirme qu'il n'a pas d'informations material adverse non divulguées et qu'aucun autre titre n'a été vendu au cours des trois derniers mois.

Nutanix, Inc. (NTNX) hat ein Formular 144 eingereicht und eine geplante Veräußerung von 11.391 Stammaktien im Wert von 892.413,09 USD angekündigt, die über Morgan Stanley Smith Barney an der NASDAQ am 16.09.2025 verkauft werden sollen. Die Einreichung weist insgesamt 268.077.453 ausstehende Aktien aus und zeigt, dass der geplante Verkauf nur einen kleinen Bruchteil des ausstehenden Stammkapitals des Unternehmens darstellt. Die Aktien wurden am 15.09.2025 als 2.100 eingeschränkte Aktien und 9.291 Performance-Aktien erworben, eine Zahlung ist nicht zutreffend. Der Einreicher versichert, dass er über keine unangekündigten wesentlichen negativen Informationen verfügt und in den letzten drei Monaten keine weiteren Wertpapiere verkauft wurden.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did NTNX report on the Form 144?

The filing reports a proposed sale of 11,391 common shares valued at $892,413.09, to be sold on 09/16/2025 via Morgan Stanley Smith Barney on NASDAQ.

What type of shares are being sold according to the filing?

The shares were acquired on 09/15/2025 as 2,100 restricted stock and 9,291 performance shares from the issuer.

How large is the proposed sale relative to NTNX outstanding shares?

The filing lists 268,077,453 shares outstanding; the proposed sale of 11,391 shares is approximately 0.0042% of that total.

Did the filer report any securities sold in the past three months?

The Form 144 states "Nothing to Report" for securities sold during the past three months by the person for whose account the securities are to be sold.

Who is the broker handling the sale?

The broker named in the filing is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004.
Nutanix Inc

NASDAQ:NTNX

NTNX Rankings

NTNX Latest News

NTNX Latest SEC Filings

NTNX Stock Data

20.40B
261.33M
0.59%
88.82%
2.89%
Software - Infrastructure
Services-prepackaged Software
Link
United States
SAN JOSE